2001
DOI: 10.1042/0264-6021:3540501
|View full text |Cite
|
Sign up to set email alerts
|

Human ornithine transcarbamylase: crystallographic insights into substrate recognition and conformational changes

Abstract: Two crystal structures of human ornithine transcarbamylase (OTCase) complexed with the substrate carbamoyl phosphate (CP) have been solved. One structure, whose crystals were prepared by substituting N-phosphonacetyl-L-ornithine (PALO) liganded crystals with CP, has been refined at 2.4 A (1 A=0.1 nm) resolution to a crystallographic R factor of 18.4%. The second structure, whose crystals were prepared by co-crystallization with CP, has been refined at 2.6 A resolution to a crystallographic R factor of 20.2%. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

5
70
0

Year Published

2002
2002
2012
2012

Publication Types

Select...
8
1

Relationship

5
4

Authors

Journals

citations
Cited by 44 publications
(75 citation statements)
references
References 58 publications
(55 reference statements)
5
70
0
Order By: Relevance
“…Our studies have identified that lysine 88 in OTC is acetylated. Interestingly, the OTC three-dimensional structure (17)(18)(19) shows that Lys 88 is not only localized near the carbamoyl phosphate-binding residues (residues 90 -93) but that it is also involved in the formation of a complex hydrogen- …”
mentioning
confidence: 99%
“…Our studies have identified that lysine 88 in OTC is acetylated. Interestingly, the OTC three-dimensional structure (17)(18)(19) shows that Lys 88 is not only localized near the carbamoyl phosphate-binding residues (residues 90 -93) but that it is also involved in the formation of a complex hydrogen- …”
mentioning
confidence: 99%
“…Further analysis of the B. fragilis ArgFЈ protein sequence revealed that a conserved Ser-Met-Gly (SMG) motif, which is present in all OTCases, was absent. This motif is part of a flexible loop that moves to cradle L-ornithine when it binds to OTCase (17,19). This difference leads us to hypothesize that the B. fragilis ArgFЈ protein represents a new class of transcarbamylase.…”
mentioning
confidence: 99%
“…Studies with aspartate and ornithine transcarbamylases demonstrated that phosphonoacetyl-L-aspartate (7) and phosphonoacetyl-L-ornithine (35) are, respectively, highly potent inert bisubstrate inhibitors of these enzymes. Since these inhibitors have been successfully used in crystallization trials with these two enzymes (21,47) that led to the determination of their three-dimensional structures by X-ray diffraction, we reasoned that PAPU might be also a very potent and highly specific inhibitor of PTC and, if so, that it might help enzyme crystallization (see below). Although PAPU was synthesized previously (41), to our knowledge it has never been used with PTC.…”
mentioning
confidence: 99%